| Literature DB >> 31333199 |
Long Khanh-Dao Le1, Lena Sanci2, Mary Lou Chatterton1, Sylvia Kauer2, Kerrie Buhagiar3, Cathrine Mihalopoulos1.
Abstract
BACKGROUND: Little empirical evidence is available to support the effectiveness and cost-effectiveness of internet interventions to increase help-seeking behavior for mental health in young adults.Entities:
Keywords: cost effectiveness; economic evaluation; help-seeking; internet intervention; mental health
Mesh:
Year: 2019 PMID: 31333199 PMCID: PMC6681639 DOI: 10.2196/13065
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Figure 1Estimation of population eligibility for the Link intervention.
Baseline characteristics of the study population.
| Characteristics | Control (n=208) | ||
| Female | 171 (83.4) | 173 (83.2) | |
| Othera | 3 (1.5) | 4 (1.9) | |
| Completed secondary school | 104 (50.7) | 99 (47.6) | |
| Higher education | 90 (43.9) | 95 (45.7) | |
| Yes | 107 (52.2) | 117 (56.3) | |
| Yes | 58 (28.3) | 71 (34.1) | |
| Mild | 28 (13.7) | 39 (18.7) | |
| Moderate | 38 (18.5) | 26 (12.5) | |
| Severe | 94 (45.8) | 96 (46.2) | |
| Some symptoms but no disease | 87 (42.4) | 85 (40.9) | |
| Minor illness | 24 (11.7) | 38 (18.3) | |
| Moderate to severe | 24 (11.7) | 24 (11.5) | |
| Some symptoms but no disease | 68 (33.2) | 60 (28.9) | |
| Minor illness | 34 (16.6) | 48 (23.1) | |
| Moderate to severe | 76 (37.1) | 72 (34.6) | |
| Yes | 79 (38.5) | 54 (26.0) | |
| Age (years), mean (SD) | 20.89 (2.32) | 21.30 (2.38) | |
| Utility score, mean (SD) | 0.56 (0.26) | 0.56 (0.26) | |
aOther includes transgender and agender participants.
bEmployment includes paid and unpaid (volunteer) workers.
cK10: Kessler-10.
dP=.01.
Health service uses at baseline and 1-month and 3-month follow-ups.
| Service typea | Baseline, n (%) | 1 month, n (%) | 3 months, n (%) | |||||
| Intervention | Control | Intervention | Control | Intervention | Control | |||
| General practitioner | 135 (65.9) | 128 (61.5) | 51 (24.9) | 53 (25.5) | 58 (28.3) | 47 (22.6) | ||
| Psychologist | 47 (22.9) | 56 (26.9) | 21 (10.2) | 22 (10.6) | 24 (11.7) | 22 (10.6) | ||
| Psychiatrist | 18 (8.8) | 27 (13.0) | 6 (2.9) | 9 (4.3) | 5 (2.4) | 7 (3.4) | ||
| Headspace | 23 (11.2) | 22 (10.6) | 14 (6.8) | 15 (7.2) | 21 (10.2) | 11 (5.3) | ||
| Other service | 16 (7.8) | 12 (5.8) | 14 (6.8) | 9 (4.3) | 13 (6.3) | 7 (3.4) | ||
| Online services | 79 (38.5)b | 54 (26.0)b | 52 (25.3) | 50 (24.0) | 38 (18.5) | 36 (17.3) | ||
| Medication | 44 (21.5) | 56 (26.9) | 19 (9.3) | 24 (11.5) | 20 (9.8) | 22 (10.6) | ||
| Hospital | 26 (12.7) | 24 (11.5) | 2 (1.0) | 6 (2.9) | 3 (1.5) | 4 (1.9) | ||
| No services used | 55 (26.8) | 57 (27.4) | 52 (25.3) | 46 (22.1) | 49 (23.9) | 57 (27.4) | ||
aSubcategories are not mutually exclusive.
bP=.01.
Mean costs per participant (in Aus $) by condition cumulative over the 1- or 3-month follow-up period (based on intention-to-treat sample, N=403).
| Costs | 1-month follow-up | 3-month follow-up | ||||
| Intervention, mean (95% CI), Aus $ | Control, mean (95% CI), Aus $ | Intervention, mean (95% CI), Aus $ | Control, mean (95% CI), Aus $ | |||
| Consultation costs | 98 (73-123) | 161 (103-220) | .01 | 214 (148-281) | 206 (139-272) | .12 |
| Hospital costsa | 35 (0-94) | 10 (0-19) | —b | 46 (0-131) | 107 (0-305) | — |
| Medication costs | 7 (3-12) | 7 (4-10) | .29 | 16 (6-25) | 11 (6-16) | .05 |
| Total costs (health care perspective) | 145 (75-214) | 178 (119-237) | .13 | 280 (168-392) | 323 (106-540) | .64 |
| Utility | 0.60 (0.56-0.64) | 0.55 (0.51-0.59) | .17 | 0.64 (0.60-0.68) | 0.56 (0.52-0.60) | .003 |
| Quality-adjusted life years | 0.049 (0.046-0.051) | 0.047 (0.044-0.049) | .37 | 0.103 (0.097-0.109) | 0.093 (0.087-0.099) | .01 |
aIncluding inpatient and outpatient hospital costs.
bInsufficient observations for the 2-part model.
Results of primary and sensitivity analyses (based on 3000 bootstrap simulations).
| Analysis | Incremental costs, Aus $ (95% CI) | Incremental effects, quality-adjusted life year (95% CI) | ICERa, mean (95% CI) | Distribution over the ICER plane (%) | ||||
| NEb | NWb | SEb | SWb | |||||
| Intention-to-treat analysis | −79 (−342 to 134) | 0.01 (0.01 to 0.02) | Dominant (dominant to Aus $11,928) | 27 | —c | 73 | — | |
| Complete case analysis | −130 (−590 to 226) | 0.01 (0.00 to 0.02) | Dominant (dominant to Aus $24,529) | 29 | — | 71 | — | |
| Dropout rate 10% (cover 17% population); cost development per case: Aus $3.82 | −85 (−363 to 134) | 0.01 (0.00 to 0.02) | Dominant (dominant to Aus $13,035) | 25 | — | 75 | — | |
| Dropout rate 90% (cover 2% population); cost development per case: Aus $34.40 | −50 (−319 to 159) | 0.01 (0.00 to 0.02) | Dominant (dominant to Aus $14,564) | 37 | — | 63 | — | |
aICER: incremental cost-effectiveness ratio, based on 3000 bootstrap simulation.
bIn the northeast (NE) quadrant, the intervention is cost-effective if the ICER falls under the specified value-for-money criterion because the intervention is more effective and costlier than the comparator. In the southeast (SE) quadrant, the intervention is less costly and more effective than the comparator (ie, dominant); therefore, the intervention is likely to be excellent for value-for-money. In the southwest (SW) quadrant, the intervention is less costly and less effective; therefore, the decision to adopt the intervention may be based on decision-makers willingness to accept some health loss relative to cost-saving. Finally, in the northwest (NW) quadrant, the results show that the intervention is associated with greater costs but less health gain, therefore, not a good option to adopt.
cNot applicable.
Figure 2Cost-effectiveness plane of 3000 replicates of the incremental cost-effectiveness ratio—intent-to-treat analysis. QALY: quality-adjusted life year.
Figure 3Cost-effectiveness acceptability curves for intent-to-treat and complete case analysis.